Secondary Tethered Cord Syndrome in Adult Patients: Retethering Rates, Long-Term Clinical Outcome, and the Effect of Intraoperative Neuromonitoring

The strategy for surgical treatment of tethered cord syndrome in pediatric patients is well established but still bares challenges for adult patients. This retrospective study was performed to assess the surgical outcome of adult patients with a secondary tethered cord syndrome and to evaluate the benefit of intraoperative neuromonitoring. Clinical charts of 32 consecutive adult patients who underwent in total 38 surgical untethering procedures at our facility between 2008 and 2018 were retrospectively analyzed. Epidemiological data, MRI scans, and postoperative results were evaluated. The retethering rate in our patient cohort was 16%. Main complaints were maximal pain (82%), bladder dysfunction (79%), paresthesia (68%), and weakness in the lower extremities (68%). Forty-eight months after surgery, patients’ symptoms generally improved, with an average level of pain of 19.1% (95% CI, 5.7–32.5%), paresthesia 28.7% (95% CI, 12.6–44.8%), weakness in the lower extremities 27.7% (95% CI, 11.1–44.4%), and bladder dysfunction 60.2% (95% CI, 41.6–78.7%). The use of neuromonitoring appears to have a positive impact on patient weakness (OR = 0.07; 95% CI, 0.01–0.68) and paresthesia (OR = 0.03; 95% CI, 0.00–2.18). This benefit is less clear for the retethering rate (OR = 0.45; 95% CI, 0.06–3.26) or the overall clinical outcome (OR = 0.70; 95% CI, 0.14–3.45). The presence of a preoperative Chiari syndrome, syringomyelia, or scoliosis had no relevant influence on the retethering rate. Our data confirms that untethering surgery in adult patients is relatively safe and has a reasonable chance of clinical improvement of pain, paresthesia, and weakness in the lower extremities. The use of intraoperative monitoring has a positive influence on the improvement of preoperative paralysis.